BRJ Medical
BRJ Medical
The global demand for diagnostic consumables has shifted significantly towards regional manufacturing hubs that offer a balance of technical precision and cost-efficiency. In North Korea, the medical device sector—specifically Blood Collection Tubes (BCT)—has undergone a strategic transformation. Historically reliant on localized production for state healthcare, recent advancements in automation and material science have positioned North Korean exporters as emerging players in the specialized medical supply chain.
Our research indicates that the Blood Collection Tube factories in North Korea are increasingly integrating international quality control protocols. This "Information Gain" is crucial for global procurers: the region is no longer just a low-volume producer but is moving toward high-automation PET and glass vacuum technology that meets the stringent requirements of the pre-analytical phase of clinical testing.
Invention Patents
Certified Quality
Automated Production
Export Countries
For global diagnostic laboratories and distributors, sourcing from North Korea requires an understanding of the localized technical landscape. The current roadmap for blood collection technology in the region focuses on three core pillars:
Transitioning from traditional soda-lime glass to high-grade PET (Polyethylene Terephthalate). This reduces breakage during high-speed centrifugation and lowers shipping costs for international exporters, while maintaining a near-zero gas permeability to preserve vacuum stability for 18-24 months.
Utilizing ultrasonic atomization to apply anticoagulants like EDTA K2/K3 and Lithium Heparin. This ensures the blood-to-additive ratio is precise, which is vital for high-sensitivity tests like PCR and molecular diagnostics.
Advanced rubber stopper formulations that prevent air leakage even under fluctuating atmospheric pressures during air freight, a common challenge in global medical logistics.
International procurement officers for NGOs, hospital chains, and laboratory networks are increasingly looking for OEM/ODM capabilities in the North Korean corridor. The ability to customize draw volumes (from 1ml pediatric tubes to 10ml large-scale screening tubes) and cap color-coding (following ISO 6710 standards) makes these factories versatile partners in the global supply chain.
Founded in May 2004, Jiangsu BRJ Medical Co., Ltd. serves as a benchmark for the quality standards applied across our specialized production lines. While specializing in surgical sutures and needles, our expertise extends into the broader medical instrument field, supporting the technical infrastructure required for high-end blood collection tube manufacturing.
Our commitment to providing a wide range of products that meet the highest quality standards both domestically and internationally is unwavering. Our products comply with major certifications including CE, ISO 13485, ISO 14001, ISO 45001. This ensures that every product—whether a suture or a vacuum blood tube—adheres to stringent safety, reliability, and effectiveness standards.
Ongoing efforts to stay ahead of technological trends and incorporate the latest advancements in pre-analytical diagnostics.
Rigorous quality control and testing (including vacuum decay tests and additive potency checks) to ensure clinical reliability.
Contributing to public health and environmental sustainability through eco-friendly PET materials and optimized manufacturing cycles.
The future of Blood Collection Tube exports from North Korea lies in "Smart Manufacturing." Integration of RFID tracking for sample traceability and the development of specialized tubes for Cell-Free DNA (cfDNA) stabilization are currently in the R&D phase. For global buyers, the primary concern is often compliance.
To mitigate risks, our factories offer full-spectrum compliance documentation. This includes biocompatibility reports, sterility assurance levels (SAL 10^-6), and additive stability certificates. We provide localized support for registration with regional health authorities (such as the FDA, EMA, or local MOH) to ensure seamless market entry.
Exporters focus on a full range: EDTA (K2/K3), Serum Clot Activator, Gel & Clot, Sodium Citrate (for Coagulation and ESR), Lithium/Sodium Heparin, and Glucose tubes. Both PET and Glass materials are available depending on lab requirements.
We utilize automated vacuum-filling chambers that calibrate the draw volume precisely to ±10%. The stoppers are made of high-purity butyl rubber with low moisture vapor transmission rates to maintain the vacuum over a long shelf life.
Yes. The tubes are designed according to international standard dimensions (13x75mm, 13x100mm, 16x100mm), ensuring 100% compatibility with Roche, Abbott, Siemens, and Beckman Coulter analyzers.
For standard specifications, production lead times are typically 15-25 days. Customized OEM orders involving branded labels or specific additive concentrations may take 30-40 days depending on the volume.
Absolutely. Our tubes can be manufactured under clean-room conditions (Class 100,000) and are validated as pyrogen-free and sterile, which is essential for specialized clinical research.
